Uganda's National Drug Authority (NDA) has approved a locally developed ulcer treatment, marking a significant milestone for the country's health sector and its push toward homegrown medical solutions. The treatment, created by Ugandan researchers, was officially cleared on May 6, 2026, according to the NDA.
The approval follows rigorous clinical trials that demonstrated the treatment's safety and efficacy. The NDA confirmed that the drug meets international standards for quality and effectiveness. This development is expected to reduce Uganda's reliance on imported medications and lower treatment costs for patients.
Local health officials have praised the achievement, noting that it showcases the potential of Ugandan scientific research. The treatment is now set to be manufactured locally, with plans for distribution across the country in the coming months.
